Self-tolerance in multiple sclerosis
Open Access
- 24 March 2012
- journal article
- review article
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 112 (2) , 133-140
Abstract
During the last decade, several defects in self-tolerance have been identified in multiple sclerosis. Dysfunction in central tolerance leads to the thymic output of antigen-specific T cells with T cell receptor alterations favouring autoimmune reactions. In addition, premature thymic involution results in a reduced export of naïve regulatory T cells, the fully suppressive clone. Alterations in peripheral tolerance concern costimulatory molecules as well as transcriptional and epigenetic mechanisms. Recent data underline the key role of regulatory T cells that suppress Th1 and Th17 effector cell responses and whose immunosuppressive activity is impaired in patients with multiple sclerosis. Those recent observations suggest that a defect in self-tolerance homeostasis might be the primary mover of multiple sclerosis leading to subsequent immune attacks, inflammation and neurodegeneration. The concept of multiple sclerosis as a consequence of the failure of central and peripheral tolerance mechanisms to maintain a self-tolerance state, particularly of regulatory T cells, may have therapeutic implications. Restoring normal thymic output and suppressive functions of regulatory T cells appears an appealing approach. Regulatory T cells suppress the general local immune response via bystander effects rather than through individual antigen-specific responses. Interestingly, the beneficial effects of currently approved immunomodulators (interferons β and glatiramer acetate) are associated with a restored regulatory T cell homeostasis. However, the feedback regulation between Th1 and Th17 effector cells and regulatory T cells is not so simple and tolerogenic mechanisms also involve other regulatory cells such as B cells, dendritic cells and CD56bright natural killer cells.Keywords
This publication has 93 references indexed in Scilit:
- Molecular and functional heterogeneity of T regulatory cellsClinical Immunology, 2011
- Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosisJournal of Autoimmunity, 2011
- Structure of a TCR with high affinity for self‐antigen reveals basis for escape from negative selectionThe EMBO Journal, 2011
- Altered miRNA expression in T regulatory cells in course of multiple sclerosisJournal of Neuroimmunology, 2010
- Thymocyte deletion can bias Treg formation toward low‐abundance self‐peptideEuropean Journal of Immunology, 2009
- Structural alterations in peptide–MHC recognition by self-reactive T cell receptorsCurrent Opinion in Immunology, 2009
- CD40 and autoimmunity: The dark side of a great activatorSeminars in Immunology, 2009
- The role of the CD58 locus in multiple sclerosisProceedings of the National Academy of Sciences, 2009
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell ProgramsImmunity, 2008
- Abnormal Tr1 differentiation in multiple sclerosisJournal of Neuroimmunology, 2007